In this slideset from Clinical Care Options, M. Dror Michaelson, MD, PhD and Robert Motzer, MD highlight key data on the optimal use of immune checkpoint inhibitors for RCC
In this slideset from Clinical Care Options, Matt Milowsky, MD provides insights on treatment for patients with bladder cancer progressing after previous therapy.
In this slideset from Clinical Care Options, Jonathan Rosenberg, MD provides insights on the latest data on managing patients with newly diagnosed bladder cancer.
In this slideset from Clinical Care Options, Dan Petrylak, MD reviews the latest data on new approaches and novel agents for bladder cancer.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.